Publication Cover
Amyloid
The Journal of Protein Folding Disorders
Volume 17, 2010 - Issue 3-4
449
Views
79
CrossRef citations to date
0
Altmetric
Original Article

The effect of curcumin on human islet amyloid polypeptide misfolding and toxicity

, , , , , & show all
Pages 118-128 | Published online: 10 Nov 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Sara Bohman & Gunilla T. Westermark. (2012) Extensive amyloid formation in transplanted microencapsulated mouse and human islets. Amyloid 19:2, pages 87-93.
Read now

Articles from other publishers (78)

Maria Chiara Pelle, Isabella Zaffina, Federica Giofrè, Roberta Pujia & Franco Arturi. (2023) Potential Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Cognitive Decline and Dementia in Diabetes Mellitus. International Journal of Molecular Sciences 24:14, pages 11301.
Crossref
Yongzhen Yang, Qin Wang, Gongjian Li, Wenjing Guo, Zuojun Yang, Hao Liu & Xiaoyuan Deng. (2023) Cysteine-Derived Chiral Carbon Quantum Dots: A Fibrinolytic Activity Regulator for Plasmin to Target the Human Islet Amyloid Polypeptide for Type 2 Diabetes Mellitus. ACS Applied Materials & Interfaces 15:2, pages 2617-2629.
Crossref
Anns Mahboob, Degiri Kalana Lasanga Senevirathne, Pradipta Paul, Faisal Nabi, Rizwan Hasan Khan & Ali Chaari. (2023) An investigation into the potential action of polyphenols against human Islet Amyloid Polypeptide aggregation in type 2 diabetes. International Journal of Biological Macromolecules 225, pages 318-350.
Crossref
Yu Zou, Bote Qi, Jingwang Tan, Yunxiang Sun, Yehong Gong & Qingwen Zhang. (2022) Mechanistic insight into the disruption of Tau R3–R4 protofibrils by curcumin and epinephrine: an all-atom molecular dynamics study. Physical Chemistry Chemical Physics 24:34, pages 20454-20465.
Crossref
Pratiksha H. Roham, Shreyada N. Save & Shilpy Sharma. (2022) Human islet amyloid polypeptide: A therapeutic target for the management of type 2 diabetes mellitus. Journal of Pharmaceutical Analysis 12:4, pages 556-569.
Crossref
Yanan Wang, Ting Zheng, Yan Huo & Weihong Du. (2022) Exploration of Isoquinoline Alkaloids as Potential Inhibitors against Human Islet Amyloid Polypeptide. ACS Chemical Neuroscience 13:14, pages 2164-2175.
Crossref
Kenana Al Adem, Aya Shanti, Amit Srivastava, Dirar Homouz, Sneha Ann Thomas, Mostafa Khair, Cesare Stefanini, Vincent Chan, Tae-Yeon Kim & Sungmun Lee. (2022) Linking Alzheimer’s Disease and Type 2 Diabetes: Characterization and Inhibition of Cytotoxic Aβ and IAPP Hetero-Aggregates. Frontiers in Molecular Biosciences 9.
Crossref
Michalis Michailidis, Despina Moraitou, Despina A. Tata, Kallirhoe Kalinderi, Theodora Papamitsou & Vasileios Papaliagkas. (2022) Alzheimer’s Disease as Type 3 Diabetes: Common Pathophysiological Mechanisms between Alzheimer’s Disease and Type 2 Diabetes. International Journal of Molecular Sciences 23:5, pages 2687.
Crossref
Chengcheng Ruan, Junhao Kong, Xiaoqian He, Bing Hu & Xiaoxiong Zeng. (2022) Interaction between polyphenols and amyloids: from the view of prevention of protein misfolding disorders related diseases. Food Materials Research 2:1, pages 1-15.
Crossref
Bani Kumar Pathak, Sandip Dey, Sukanya Mozumder & Jayati Sengupta. 2022. Membrane Proteins. Membrane Proteins 397 434 .
Tina Nie & Garth J. S. Cooper. (2021) Mechanisms Underlying the Antidiabetic Activities of Polyphenolic Compounds: A Review. Frontiers in Pharmacology 12.
Crossref
Shabnam Radbakhsh, George E. Barreto, Abigail R. Bland & Amirhossein Sahebkar. (2021) Curcumin: A small molecule with big functionality against amyloid aggregation in neurodegenerative diseases and type 2 diabetes. BioFactors 47:4, pages 570-586.
Crossref
Yuanyuan Liu, Lin Cong, Chu Han, Bo Li & Rongji Dai. (2021) Recent Progress in the Drug Development for the Treatment of Alzheimer’s Disease Especially on Inhibition of Amyloid-peptide Aggregation. Mini-Reviews in Medicinal Chemistry 21:8, pages 969-990.
Crossref
Anisha Thomas, Gagandeep Kaur, Rafat Ali & Sandeep Verma. 2021. Biological Soft Matter. Biological Soft Matter 153 193 .
Phuong H. Nguyen, Ayyalusamy Ramamoorthy, Bikash R. Sahoo, Jie Zheng, Peter Faller, John E. Straub, Laura Dominguez, Joan-Emma Shea, Nikolay V. Dokholyan, Alfonso De Simone, Buyong Ma, Ruth Nussinov, Saeed Najafi, Son Tung Ngo, Antoine Loquet, Mara ChiricottoPritam Ganguly, James McCarty, Mai Suan Li, Carol Hall, Yiming Wang, Yifat Miller, Simone Melchionna, Birgit Habenstein, Stepan Timr, Jiaxing Chen, Brianna Hnath, Birgit Strodel, Rakez Kayed, Sylvain Lesné, Guanghong Wei, Fabio Sterpone, Andrew J. Doig & Philippe Derreumaux. (2021) Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer’s Disease, Parkinson’s Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis. Chemical Reviews 121:4, pages 2545-2647.
Crossref
Sabine Szunerits, Sorin Melinte, Alexandre Barras, Quentin Pagneux, Anna Voronova, Amar Abderrahmani & Rabah Boukherroub. (2021) The impact of chemical engineering and technological advances on managing diabetes: present and future concepts. Chemical Society Reviews 50:3, pages 2102-2146.
Crossref
Jufei Xu, Ting Zheng, Cong Zhao, Xiangyi Huang & Weihong Du. (2021) Resistance of nepetin and its analogs on the fibril formation of human islet amyloid polypeptide. International Journal of Biological Macromolecules 166, pages 435-447.
Crossref
Yijing Tang, Dong Zhang, Yanxian Zhang, Yonglan Liu, Xiong Gong, Yung Chang, Baiping Ren & Jie Zheng. (2020) Introduction and Fundamentals of Human Islet Amyloid Polypeptide Inhibitors. ACS Applied Bio Materials 3:12, pages 8286-8308.
Crossref
Daniel Nir Bloch, Shani Ben Zichri, Sofiya Kolusheva & Raz Jelinek. (2020) Tyrosine carbon dots inhibit fibrillation and toxicity of the human islet amyloid polypeptide. Nanoscale Advances 2:12, pages 5866-5873.
Crossref
Debabrata Maity, Sunil Kumar, Ruyof AlHussein, Lothar Gremer, Madeline Howarth, Laura Karpauskaite, Wolfgang Hoyer, Mazin Magzoub & Andrew D. Hamilton. (2020) Sub-stoichiometric inhibition of IAPP aggregation: a peptidomimetic approach to anti-amyloid agents. RSC Chemical Biology 1:4, pages 225-232.
Crossref
Rohith N Thota, Jessica I Rosato, Cintia B Dias, Tracy L Burrows, Ralph N Martins & Manohar L Garg. (2020) Dietary Supplementation with Curcumin Reduce Circulating Levels of Glycogen Synthase Kinase-3β and Islet Amyloid Polypeptide in Adults with High Risk of Type 2 Diabetes and Alzheimer’s Disease. Nutrients 12:4, pages 1032.
Crossref
Jordi Pujols, Samuel Peña-Díaz, Irantzu Pallarès & Salvador Ventura. (2020) Chemical Chaperones as Novel Drugs for Parkinson’s Disease. Trends in Molecular Medicine 26:4, pages 408-421.
Crossref
Seyed Mahmoud Puormand, Arezou Ghahghaei, Jafar Valizadeh & Shahrzad Nazari. (2020) Protective Ability of Perovskia abrotanoides Karel Root Extract on the Aggregation of Protein In Vitro. The Natural Products Journal 10:2, pages 113-121.
Crossref
Ana F. Raimundo, Sofia Ferreira, Ivo C. Martins & Regina Menezes. (2020) Islet Amyloid Polypeptide: A Partner in Crime With Aβ in the Pathology of Alzheimer's Disease. Frontiers in Molecular Neuroscience 13.
Crossref
Ana R. Araújo, Rui L. Reis & Ricardo A. Pires. 2020. Biomimicked Biomaterials. Biomimicked Biomaterials 159 176 .
Manikam S. Saravanan, Sergey Ryazanov, Andrei Leonov, Janine Nicolai, Patrique Praest, Armin Giese, Roland Winter, Lucie Khemtemourian, Christian Griesinger & J. Antoinette Killian. (2019) The small molecule inhibitor anle145c thermodynamically traps human islet amyloid peptide in the form of non-cytotoxic oligomers. Scientific Reports 9:1.
Crossref
Ammu Prasanna Kumar, Sungmun Lee & Suryani Lukman. (2019) Computational and Experimental Approaches to Design Inhibitors of Amylin Aggregation. Current Drug Targets 20:16, pages 1680-1694.
Crossref
Xufeng Zhu, Yayu Wen, Yingyu Zhao, Yanan Liu, Jing Sun, Jiawei Liu, Jie Liu & Lanmei Chen. (2019) Functionalized chitosan-modified defect-related luminescent mesoporous silica nanoparticles as new inhibitors for hIAPP aggregation. Nanotechnology 30:31, pages 315705.
Crossref
Katarina Siposova, Tibor Kozar, Veronika Huntosova, Silvia Tomkova & Andrey Musatov. (2019) Inhibition of amyloid fibril formation and disassembly of pre-formed fibrils by natural polyphenol rottlerin. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1867:3, pages 259-274.
Crossref
Márta Kotormán, Alexandra Varga, Phanindra Babu Kasi & János Nemcsók. (2018) Inhibition of the formation of amyloid-like fibrils with spices, especially cloves. Acta Biologica Hungarica 69:4, pages 385-394.
Crossref
Zohra Dhouafli, Karina Cuanalo-Contreras, El Akrem Hayouni, Charles E. Mays, Claudio Soto & Ines Moreno-Gonzalez. (2018) Inhibition of protein misfolding and aggregation by natural phenolic compounds. Cellular and Molecular Life Sciences 75:19, pages 3521-3538.
Crossref
Yoona Kim & Peter Clifton. (2018) Curcumin, Cardiometabolic Health and Dementia. International Journal of Environmental Research and Public Health 15:10, pages 2093.
Crossref
Shreyasi Asthana, Bibekanand Mallick, Andrei T. Alexandrescu & Suman Jha. (2018) IAPP in type II diabetes: Basic research on structure, molecular interactions, and disease mechanisms suggests potential intervention strategies. Biochimica et Biophysica Acta (BBA) - Biomembranes 1860:9, pages 1765-1782.
Crossref
Sunil Kumar, Maria C. Vogel & Andrew D. Hamilton. (2018) Teaching an old scaffold new recognition tricks: oligopyrrolamide antagonists of IAPP aggregation. Organic & Biomolecular Chemistry 16:5, pages 733-741.
Crossref
Ana Marta de Matos, Maria Paula de Macedo & Amélia Pilar Rauter. (2018) Bridging Type 2 Diabetes and Alzheimer's Disease: Assembling the Puzzle Pieces in the Quest for the Molecules With Therapeutic and Preventive Potential. Medicinal Research Reviews 38:1, pages 261-324.
Crossref
Bibekananda Sarkar, Monisha Dhiman, Sunil Mittal & Anil K. Mantha. (2017) Curcumin revitalizes Amyloid beta (25–35)-induced and organophosphate pesticides pestered neurotoxicity in SH-SY5Y and IMR-32 cells via activation of APE1 and Nrf2. Metabolic Brain Disease 32:6, pages 2045-2061.
Crossref
Palak Patel, Krupali Parmar, Vivek K. Vyas, Dhaval Patel & Mili Das. (2017) Combined in silico approaches for the identification of novel inhibitors of human islet amyloid polypeptide (hIAPP) fibrillation. Journal of Molecular Graphics and Modelling 77, pages 295-310.
Crossref
Etheresia Pretorius, Sthembile Mbotwe & Douglas B. Kell. (2017) Lipopolysaccharide-binding protein (LBP) reverses the amyloid state of fibrin seen in plasma of type 2 diabetics with cardiovascular co-morbidities. Scientific Reports 7:1.
Crossref
Alan K. Okada, Kazuki Teranishi, Fleur Lobo, J. Mario Isas, Jialin Xiao, Kelvin Yen, Pinchas Cohen & Ralf Langen. (2017) The Mitochondrial-Derived Peptides, HumaninS14G and Small Humanin-like Peptide 2, Exhibit Chaperone-like Activity. Scientific Reports 7:1.
Crossref
Ivana Sequeira & Sally Poppitt. (2017) Unfolding Novel Mechanisms of Polyphenol Flavonoids for Better Glycaemic Control: Targeting Pancreatic Islet Amyloid Polypeptide (IAPP). Nutrients 9:7, pages 788.
Crossref
Belinda Schludi, Abu Saleh Md Moin, Chiara Montemurro, Tatyana Gurlo, Aleksey V. Matveyenko, David Kirakossian, David W. Dawson, Sarah M. Dry, Peter C. Butler & Alexandra E. Butler. (2017) Islet inflammation and ductal proliferation may be linked to increased pancreatitis risk in type 2 diabetes. JCI Insight 2:13.
Crossref
Basir Ahmad, Mohanish S. Borana & Ankur P. Chaudhary. (2017) Understanding curcumin-induced modulation of protein aggregation. International Journal of Biological Macromolecules 100, pages 89-96.
Crossref
Cristy Phillips. (2017) Lifestyle Modulators of Neuroplasticity: How Physical Activity, Mental Engagement, and Diet Promote Cognitive Health during Aging. Neural Plasticity 2017, pages 1-22.
Crossref
Pu Chun Ke, Marc-Antonie Sani, Feng Ding, Aleksandr Kakinen, Ibrahim Javed, Frances Separovic, Thomas P. Davis & Raffaele Mezzenga. (2017) Implications of peptide assemblies in amyloid diseases. Chemical Society Reviews 46:21, pages 6492-6531.
Crossref
K. Rashid & P.C. Sil. 2017. Discovery and Development of Antidiabetic Agents from Natural Products. Discovery and Development of Antidiabetic Agents from Natural Products 63 111 .
J.E. Gerson, F.L. Cascio & R. Kayed. 2017. Neuroprotection in Alzheimer's Disease. Neuroprotection in Alzheimer's Disease 97 121 .
Silvia Molino, Maurizia Dossena, Daniela Buonocore, Federica Ferrari, Letizia Venturini, Giovanni Ricevuti & Manuela Verri. (2016) Polyphenols in dementia: From molecular basis to clinical trials. Life Sciences 161, pages 69-77.
Crossref
Alan K. Okada, Kazuki Teranishi, J. Mario Isas, Sahar Bedrood, Robert H. Chow & Ralf Langen. (2016) Diabetic Risk Factors Promote Islet Amyloid Polypeptide Misfolding by a Common, Membrane-mediated Mechanism. Scientific Reports 6:1.
Crossref
M. Ankarcrona, B. Winblad, C. Monteiro, C. Fearns, E. T. Powers, J. Johansson, G. T. Westermark, J. Presto, B.-G. Ericzon & J. W. Kelly. (2016) Current and future treatment of amyloid diseases. Journal of Internal Medicine 280:2, pages 177-202.
Crossref
Praveen Nedumpully-Govindan, Aleksandr Kakinen, Emily H. Pilkington, Thomas P. Davis, Pu Chun Ke & Feng Ding. (2016) Stabilizing Off-pathway Oligomers by Polyphenol Nanoassemblies for IAPP Aggregation Inhibition. Scientific Reports 6:1.
Crossref
Paola C. Rosas, Ganachari M. Nagaraja, Punit Kaur, Alexander Panossian, Georg Wickman, L. Rene Garcia, Fahd A. Al-Khamis & Alexzander A. A. Asea. (2016) Hsp72 (HSPA1A) Prevents Human Islet Amyloid Polypeptide Aggregation and Toxicity: A New Approach for Type 2 Diabetes Treatment. PLOS ONE 11:3, pages e0149409.
Crossref
Jessica S. FortinMarie-Odile Benoit-BiancamanoRené C.-Gaudreault. (2016) Discovery of ethyl urea derivatives as inhibitors of islet amyloid polypeptide fibrillization and cytotoxicity. Canadian Journal of Physiology and Pharmacology 94:3, pages 341-346.
Crossref
Esteban N. Gurzov, Bo Wang, Emily H. Pilkington, Pengyu Chen, Aleksandr Kakinen, William J. Stanley, Sara A. Litwak, Eric G. Hanssen, Thomas P. Davis, Feng Ding & Pu Chun Ke. (2016) Inhibition of hIAPP Amyloid Aggregation and Pancreatic β-Cell Toxicity by OH-Terminated PAMAM Dendrimer. Small 12:12, pages 1615-1626.
Crossref
Janet C Saunders, Lydia M Young, Rachel A Mahood, Matthew P Jackson, Charlotte H Revill, Richard J Foster, D Alastair Smith, Alison E Ashcroft, David J Brockwell & Sheena E Radford. (2015) An in vivo platform for identifying inhibitors of protein aggregation. Nature Chemical Biology 12:2, pages 94-101.
Crossref
Lucie Caillon, Anais R. F. Hoffmann, Alexandra Botz & Lucie Khemtemourian. (2016) Molecular Structure, Membrane Interactions, and Toxicity of the Islet Amyloid Polypeptide in Type 2 Diabetes Mellitus. Journal of Diabetes Research 2016, pages 1-13.
Crossref
Qing Sun, Juan Zhao, Yuan Zhang, Hongjie Yang & Ping Zhou. (2016) A natural hyperbranched proteoglycan inhibits IAPP amyloid fibrillation and attenuates β-cell apoptosis. RSC Advances 6:107, pages 105690-105698.
Crossref
Cong-Heng Chen, Ting Yao, Qiang Zhang, Yan-Ming He, Li-Hui Xu, Min Zheng, Guang-Rong Zhou, Yuan Zhang, Hong-Jie Yang & Ping Zhou. (2016) Influence of trehalose on human islet amyloid polypeptide fibrillation and aggregation. RSC Advances 6:18, pages 15240-15246.
Crossref
Paola Florio, Claudia Folli, Michele Cianci, Daniele Del Rio, Giuseppe Zanotti & Rodolfo Berni. (2015) Transthyretin Binding Heterogeneity and Anti-amyloidogenic Activity of Natural Polyphenols and Their Metabolites. Journal of Biological Chemistry 290:50, pages 29769-29780.
Crossref
Lianqi Huang & Kun Huang. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences 1 8 .
Jessica S. Fortin & Marie-Odile Benoit-Biancamano. (2015) In Vitro Evaluation of Hypoglycemic Agents to Target Human Islet Amyloid Polypeptide: A Key Protein Involved in Amyloid Deposition and Beta-Cell Loss. Canadian Journal of Diabetes 39:5, pages 373-382.
Crossref
Viviane L. Ndam Ngoungoure, Jan Schluesener, Paul F. Moundipa & Hermann Schluesener. (2015) Natural polyphenols binding to amyloid: A broad class of compounds to treat different human amyloid diseases. Molecular Nutrition & Food Research 59:1, pages 8-20.
Crossref
MohammedTalaat Abdel Aziz, Mohammed Farid El-Asmar, Ameen Mahmoud Rezq, MohammedAbdel Aziz Wassef, Hanan Fouad, Nagwa Kamal Roshdy, Hanan Hosni Ahmed, Laila Ahmed Rashed, Dina Sabry, Fatma Mohammed Taha & Amira Hassouna. (2014) Effects of a novel curcumin derivative on insulin synthesis and secretion in streptozotocin-treated rat pancreatic islets in vitro. Chinese Medicine 9:1.
Crossref
Massimo Stefani & Stefania Rigacci. (2014) Beneficial properties of natural phenols: Highlight on protection against pathological conditions associated with amyloid aggregation. BioFactors 40:5, pages 482-493.
Crossref
Marcos J. Guerrero-Muñoz, Diana L. Castillo-Carranza & Rakez Kayed. (2014) Therapeutic approaches against common structural features of toxic oligomers shared by multiple amyloidogenic proteins. Biochemical Pharmacology 88:4, pages 468-478.
Crossref
Benny Kwong Huat Tan & Khang Wei Ong. 2014. Polyphenols in Human Health and Disease. Polyphenols in Human Health and Disease 95 111 .
Biao Cheng, Hao Gong, Hongwen Xiao, Robert B. Petersen, Ling Zheng & Kun Huang. (2013) Inhibiting toxic aggregation of amyloidogenic proteins: A therapeutic strategy for protein misfolding diseases. Biochimica et Biophysica Acta (BBA) - General Subjects 1830:10, pages 4860-4871.
Crossref
Carolyn Berdanier, Johanna Dwyer & David HeberZhaoping Li & David Heber. 2013. Handbook of Nutrition and Food, Third Edition. Handbook of Nutrition and Food, Third Edition 893 900 .
Massimo Stefani & Stefania Rigacci. (2013) Protein Folding and Aggregation into Amyloid: The Interference by Natural Phenolic Compounds. International Journal of Molecular Sciences 14:6, pages 12411-12457.
Crossref
Dong-wei Zhang, Min Fu, Si-Hua Gao & Jun-Li Liu. (2013) Curcumin and Diabetes: A Systematic Review. Evidence-Based Complementary and Alternative Medicine 2013, pages 1-16.
Crossref
Atefeh Rabiee, Azadeh Ebrahim-Habibi, Atiyeh Ghasemi & Mohsen Nemat-Gorgani. (2013) How curcumin affords effective protection against amyloid fibrillation in insulin. Food & Function 4:10, pages 1474.
Crossref
Sean D. Moran, Sean M. Decatur & Martin T. Zanni. (2012) Structural and Sequence Analysis of the Human γD-Crystallin Amyloid Fibril Core Using 2D IR Spectroscopy, Segmental 13 C Labeling, and Mass Spectrometry . Journal of the American Chemical Society 134:44, pages 18410-18416.
Crossref
Gai Liu, Jennifer C. Gaines, Kevin J. Robbins & Noel D. Lazo. (2012) Kinetic Profile of Amyloid Formation in the Presence of an Aromatic Inhibitor by Nuclear Magnetic Resonance. ACS Medicinal Chemistry Letters 3:10, pages 856-859.
Crossref
Maarten F. M. Engel, Corianne C. vandenAkker, Michael Schleeger, Krassimir P. Velikov, Gijsje H. Koenderink & Mischa Bonn. (2012) The Polyphenol EGCG Inhibits Amyloid Formation Less Efficiently at Phospholipid Interfaces than in Bulk Solution. Journal of the American Chemical Society 134:36, pages 14781-14788.
Crossref
Emanuela Maioli, Claudia Torricelli & Giuseppe Valacchi. (2012) Rottlerin and curcumin: a comparative analysis. Annals of the New York Academy of Sciences 1259:1, pages 65-76.
Crossref
Samuel Sparks, Gai Liu, Kevin J. Robbins & Noel D. Lazo. (2012) Curcumin modulates the self-assembly of the islet amyloid polypeptide by disassembling α-helix. Biochemical and Biophysical Research Communications 422:4, pages 551-555.
Crossref
Owen Griffith Jones & Raffaele Mezzenga. (2012) Inhibiting, promoting, and preserving stability of functional proteinfibrils. Soft Matter 8:4, pages 876-895.
Crossref
Biao Cheng, Xinran Liu, Hao Gong, Lianqi Huang, Hong Chen, Xin Zhang, Chuanzhou Li, Muyang Yang, Bingjun Ma, Lihua Jiao, Ling Zheng & Kun Huang. (2011) Coffee Components Inhibit Amyloid Formation of Human Islet Amyloid Polypeptide in Vitro: Possible Link between Coffee Consumption and Diabetes Mellitus. Journal of Agricultural and Food Chemistry 59:24, pages 13147-13155.
Crossref
Pradyot Koley & Animesh Pramanik. (2011) Nanostructures from Single Amino Acid-Based Molecules: Stability, Fibrillation, Encapsulation, and Fabrication of Silver Nanoparticles. Advanced Functional Materials 21:21, pages 4126-4136.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.